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Indeed, when either of these genes are expressed in
budding yeast they can rescue cdc28 mutations, per-The first molecular models of cell cycle regulation fo-
cused on how a single enzymatic oscillator, comprised forming both its S and M phase functions (Elledge and
Spottswood, 1991).of a B-type cyclin and a cyclin-dependent kinase (CDK)
controlled mitotic entry and exit. However, these elegant A different explanation for the specific actions of
CDKs is that their regulatory subunits, the cyclins, areand relatively simple models were soon recognized to
be insufficient to account for the roles that CDKs play the major determinants of their biological specificity.
All eukaryotes express multiple cyclins which assemblein multiple cell cycle events, including DNA replication,
mitosis, centrosome/spindle pole body duplication, and into complexes with CDKs in various combinatorial ar-
rangements, controlling the patterns and level of CDKcell morphogenetic changes.
Various explanations were then considered for how activity, and perhaps also playing roles in substrate se-
lection (Figure 1A). Thus, each stage of the cell cycle canCDKs could control the orderly operation of the cell
cycle, especially the regular alternation of S and M be characterized by its unique collection of cyclin±CDK
complexes. It was not unreasonable to think that eachphases. An early debate was over whether the ability to
induce temporally specific events was intrinsic to the different cyclin±CDK complex would execute distinct
cell cycle events and that the sequential assembly andCDK holoenzyme, or alternatively whether the changing
state of the cell determined the particular cell cycle activation of these complexes could explain, at least in
part, the order in which cell cycle events occur.events that happened in response to CDK activation.
Both factors probably contribute, but there is strong In fact, there is little doubt that different cyclins can
have intrinsically different biological actions. On the oneevidence that the CDK is critically important (Stern and
Nurse, 1996 and references therein). Thus, premature hand, there is a very clear distinction between the events
that can be induced by the G1 versus S/G2 cyclins. InCDK activation in G1 can cause a cell to skip S phase
and proceed directly to mitosis. Other manipulations of both budding and fission yeast, the S/G2 cyclins can
initiate S phase and mitosis whereas the G1 cyclinsCDK activity (for instance, turning the enzyme off and
back on again) can cause a G2 cell to reenter S phase cannot (Schwob and Nasmyth, 1993; Fisher and Nurse,
1996). Conversely, the G1 cyclins can perform functionswithout an intervening mitosis.
The idea that biological specificity resides in the CDK that the B-type cyclins cannot, one example being the
unique ability of the G1 cyclins in budding yeast to re-holoenzyme itself presents a paradox. In yeast, a single
CDK is responsible for initiating all cell cycle transitions press the mating pathway (Oehlen et al., 1998) and an-
other the inability of the yeast B-type cyclins to activate(CDC28 in S. cerevisiae and CDC2 in S. pombe, referred
to here generically as CDK1). What explains its specific the G1 transcriptional program (see Nasmyth, 1996 and
references therein). Moreover, there are further func-effects at different times in the cell cycle? In higher
eukaryotes the CDKs have evolved into small gene fami- tional divisions within these groups. The budding yeast
G1 cyclins (the Cln proteins), which had been thoughtlies whose individual members appear to be more impor-
tant for one cell cycle phase or the other. CDK2, for to be functionally redundant, turn out to be qualitatively
Figure 1. Qualitative and Quantitative Views of Cell Cycle Regulation
(A) The qualitative model. Special cyclins are needed for each phase of the cell cycle.
(B) The quantitative model. The figure depicts three CDK-modulated cell cycle events and represents how their execution may depend on
the amount, not the type, of CDK activity. See text for details.
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different in terms of the cell cycle events they stimulate the hydrophobic patch or in the substrate RxL motif
decrease both substrate binding and substrate phos-(Levine et al., 1996). Although any one of the three CLN
genes is sufficient for transit through G1, the particular phorylation. Indeed, the ability of cyclin A to induce entry
into S phase is decreased by these same hydrophobicpathways by which this happens depend upon whether
it is Cln3p or Cln1/2p that is expressed. Cln3p seems patch mutations, demonstrating a concordance be-
tween cyclin A biological specificity and substrate selec-to be an especially potent activator of the G1 transcrip-
tional program, whereas Clns 1p and 2p can more di- tivity. The hydrophobic patch in cyclin A is also found
in the D-, E-, and B-type cyclins. Therefore, this patchrectly activate G1 events such as bud emergence and
cell morphogenesis. is unlikely on its own to be responsible for substrate
selectivity, but may be a conserved substrate-dockingThe biological specificity of individual cyclins sug-
gests that different cyclin-CDK complexes may have domain whose selectivity is influenced by context and
conformation.intrinsically distinct substrate preferences. Only a small
number CDK substrates have been identified so its been A Quantitative Model for CDK Action
A very different perspective on cyclin specializationdifficult to establish the generality of this idea. But in
the few cases where it has been tested, it seems that came from the work of Fisher and Nurse (1996), who
reported that the cell cycle of the fission yeast S. pombethe ability of a CDK to phosphorylate a specific target
protein depends on the particular cyclin to which it is could run on a single B-type cyclin. A similar concept
also emerged from Nasymth's lab based on experimentsbound. Some examples of this are that cyclin A±CDK1
and cyclin B±CDK1 phosphorylate histone H1 on differ- in budding yeast (Nasmyth, 1996), suggesting that com-
plex models involving cyclin specialization might haveent sites; that cyclin A±CDK2 but not cyclin B±CDK2
can phosphorylate the retinoblastoma-related protein missed an important underlying principle that could sim-
plify our view of cell cycle regulation. There are threep107; and that cyclin A±CDK2 but not cyclin E±CDK2
can phosphorylate the transcription factor DP1 (see known fission yeast cyclins: Cig1, which plays a role in
G1, Cig2, which is an S phase cyclin, and Cdc13, a B-typeSchulman et al., and references therein).
It is possible that cyclins affect CDK substrate choice that is essential for mitosis. All three cyclins use CDK1
as their catalytic subunit. Deletion of Cig1 and Cig2by changing the structure of the CDK catalytic cleft,
perhaps through allosteric interactions, thereby altering leaves Cdc13±CDK1 as the only known cyclin±CDK
complex, and remarkably cells expressing just this onethe affinity of the CDK for particular substrates. Indeed,
the crystal structures of the CDK2 and cyclin A±CDK2 cyclin±CDK enzyme proliferate normally. These obser-
vations seemed to undermine the idea that qualitativelycomplexes show that binding of the cyclin to the CDK
does alter the shape of the CDK both by reconfiguring different cyclins are needed to control the regular alter-
nation of S and M phases.the residues involved in ATP binding, and by reposition-
ing the CDK T loop (the site of phosphorylation by the To account for these results a quantitative model for
cell cycle regulation was proposed (Stern and Nurse,CDK-activating kinase) so that it does not completely
obstruct the enzyme's catalytic cleft (Jeffrey et al., 1995). 1996) (Figure 1B). According to this model it is the
amount of CDK activity that determines whether a cellHowever, these changes facilitate phosphorylation of
protein substrates in a general sense and do not seem will initiate S phase or mitosis, not the qualitative attri-
butes of any particular cyclin±CDK complex. Moderateto be involved in remodeling the catalytic cleft so that
it would recognize one substrate better than another amounts of CDK activity would be sufficient to initiate
S phase whereas higher amounts would be needed for(Holmes and Solomon, 1996).
Another way that cyclins could contribute to substrate mitosis. Alternation of S and M phases would be an
automatic outcome of the steady rise and fall of a unitarypreference is by directly binding to substrates. This was
first shown for the D-type cyclin±CDK complexes, CDK activity during each cell cycle.
A particularly appealing feature of this model is thatwhose efficient phosphorylation of the Rb protein is
enhanced by an interaction between an LxCxE motif in it could neatly accommodate the additional regulatory
requirements that mitosis not begin until S phase isthe amino terminus of cyclin D and the Rb protein (Sherr,
1993). This motif is present in other proteins that bind finished, and that S phase be restricted to once per cell
cycle. The coupling of mitosis to the completion of Sdirectly and tightly to Rb, such as the E7 oncoprotein
from papillomaviruses, and the E1A protein from adeno- phase could be accomplished by postulating that ongo-
ing DNA replication inhibits the rise in CDK activity toviruses. Cyclin E contains a similar motif that is also
important for binding to, and phosphorylation of, Rb by mitotic levels. In this way mitosis would be held in check
until S phase was completed. The second problem, thatcyclin E±CDK2.
The ability of cyclins to act as targeting subunits for of preventing rereplication in a single cell cycle, could
be dealt with by supposing that the initiation of DNAthe holoenzyme is not restricted to the special case of
cyclin D binding to Rb. A second region involved in replication is a two-step process: first, loading of repli-
cation proteins at replication origins and second, trig-substrate docking is a conserved hydrophobic patch on
the surface of the cyclin (Schulman et al., 1998). This gering of those initiation complexes to begin DNA repli-
cation (see Nasmyth, 1996 and references therein). Insurface groove was first seen in the cyclin A±CDK2±
p27Kip1 crystal structure as the site on the cyclin where order to make the model work it must then be the case
that the first step is inhibited by CDKs and the secondthe CDK inhibitor p27Kip1 binds (Russo et al., 1996). The
p27 residues that sit in this groove (the RxL motif) are step activated by CDKs. Cells would then assemble
initiation complexes at the conclusion of mitosis whenconserved in other cyclin A±binding proteins, many or
all of which are also CDK2 substrates including p107, the level of CDK activity is at a minimum, and then trigger
those complexes to begin replication when CDK activityp130, E2F, and even Rb. Moreover, mutations either in
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increases to the appropriate level at the end of G1. overexpression of CDK inhibitors (Sheaff et al., 1997).
When Rb phosphorylation and Kip/Cip sequestrationThe high amounts of CDK activity that persist for the
remainder of the cell cycle would prevent the replication are examined in the cyclin E→D1 knockin mice, it ap-
peared that cyclin D1 functions were being bypassedcycle from beginning again until CDK activity was re-
stored to its basal state after the next mitosis. by the ectopic cyclin E, not replaced; Rb phosphoryla-
tion did not proceed to completion in the knockin miceCyclin Specialization Revisited
Two new papers have reexamined the issue of cyclin nor were the Kip/Cip proteins sequestered onto the ec-
topic cyclin E±CDK complexes. Therefore, the majorspecificity. Geng, Sicinski, and colleagues (Geng et al.,
1999) compared the functions of the mammalian G1 conclusion of Geng et al.'s definitive work is that cyclin
D1 and cyclin E act in sequence, and that cyclin E iscyclins D1 and E, and Cross and coworkers compared
the budding yeast S/G2 cyclins CLB5 and CLB2 (Cross the major downstream target of cyclin D1. What is hap-
pening to the rest of the E2F transcriptional program inet al, 1999). The results from both groups strongly em-
phasize the idea that cyclins have specialized functions. these mice is not known, and it would be very surprising
if this program were entirely dispensible when cyclin EThe results from Cross et al. suggest that the quantita-
tive view of cyclin function may not be widely applicable, is constitutively activated.
These results parallel the ones discussed above re-and the results from Geng et al. sharpen our view of
how cyclin D1 controls progression through G1. garding the functions of the G1 cyclin genes in budding
yeast. The D-type cyclins, like CLN3, are specialized forThe experiments of Geng et al. used knockout and
knockin mice in which the cyclin D1 locus was either activation of the G1 transcriptional program whereas
cyclin E, like CLN1/2 (or perhaps CLB5/6), is more in-deleted or replaced with cyclin E coding exons. Sicinski,
together with Weinberg, had previously found that mice volved in directly activating the downstream events of
G1 progression (or entry into S phase). In yeast, as nowlacking the cyclin D1 gene have specific deficits, includ-
ing decreased proliferation of cells in the mammary seen in mammalian cells, ectopic expression of the
downstream cyclin overcomes the need for the up-gland and retina, and an undefined neurological abnor-
mality (Sicinski et al., 1995). To explore the functional stream one, although the actual pathways used to enter
S phase are subtly different. Previous work had showndifferences between cyclins D1 and E, they made homo-
zygous mice in which the cyclin D1 genomic coding that expression of the CLN2 gene from the CLN3 pro-
moter is sufficient for G1 progression (Levine et al.,sequences were replaced with those encoding cyclin E.
These mice make no cyclin D1, but instead transcribe 1996), an observation that is quite analogous to the one
reported by Sicinski.a cyclin E message from the cyclin D1 promoter (note
that the normal cyclin E gene is still present in these One additional point deserves comment. Cyclin D1
had recently been proposed to have a CDK-independentmice, and its expression was not affected by the new
cyclin E→D1 gene). As a result, cyclin E protein is ex- function as a coactivator of the estrogen receptor (ER)
(Zwijsen et al., 1997). It was suggested that this interac-pressed with the correct developmental timing and tis-
sue specificity of cyclin D1. This was found to rescue tion might, in part, account for the hypoplasia of the
mammary epithelium in the cyclin D1 knockout mice,all of the known defects of the cyclin D1 knockout
mouse. Also, no new phenotypes were associated with and perhaps for hyperplasia of these cells in human
tumors overexpressing cyclin D1. However, cyclin Eectopic expression of cyclin E.
These results may be a surprise to those who have does not interact with the ER. Therefore, rescue of mam-
mary gland development in the E→D1 knockin mousegrown used to the idea that cyclin D1 and cyclin E have
very different functions during G1. Indeed, at first glance, argues that cyclin D1's interaction with the ER is not
important for understanding its actions in these cells.they may seem to support the idea that it is the timing of
cyclin expression rather than their particular qualitative Clear evidence for functional specialization among the
B-type cyclins comes from the results of Cross et al.attributes that determines their biological functions.
However, a key issue is whether cyclin E is performing Budding yeast express six B-type cyclins among which
CLB5 and -6 appear earliest in the cell cycle and arethe functions normally carried out by cyclin D1, or
whether it is activating the cell cycle at a downstream necessary for S phase, while CLB1 and -2 appear later
and are required for mitosis. Cross replaced the chromo-step and bypassing the need for cyclin D1. Sicinski and
colleagues suggest that the latter is more likely. somal CLB5 coding region with CLB2, thereby putting
CLB2 gene expression under control of the chromo-Cyclin D1 performs two known functions during G1.
One is phosphorylation of Rb, which regulates the Rb/ somal CLB5 promoter. This hybrid gene was functional,
as it was able to rescue the lethality caused by deletionE2F transcriptional program. The other is sequestration
of CDK inhibitors in the Kip/Cip family. Both of these of CLB1 and -2. It was carefully shown that the timing
of Clb protein expression and the amount of Clb-associ-have the effect of activating cyclin E, the first by inducing
E2F-mediated cyclin E gene transcription, and the sec- ated CDK activity closely corresponded to what hap-
pens in a normal yeast cell at the start of S phase. Theond by decreasing the inhibitory threshold imposed by
the pool of free CDK inhibitors in the cell. Thus, there only difference was that the actual cyclin±CDK complex
being expressed was qualitatively different, containingwas reason to believe that activation of cyclin E may
render the upstream roles of cyclin D1 unnecessary. Clb2p instead of Clb5p. Under these conditions it was
found that Clb2p was extremely poor at promoting theIn fact, transfection experiments in cultured cells had
shown that ectopic expression of cyclin E would (at least start of S phase, demonstrating that Clb5p is somehow
specialized for DNA replication. Prior work (Nasmyth,in the short term) overcome cell cycle blocks imposed
either by expression of a phosphorylation-deficient Rb 1996) suggesting that CLB2 could initiate S phase relied
on CLB2 overexpression and, therefore, could haveprotein (Leng et al., 1997; Lukas et al., 1997), or by
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missed significant differences in efficiency between come later, as CDKs evolved to become dependent on
CLB2 and CLB5. The converse was also shown: that cyclins for their activity. This could have occurred as a
Clb5p cannot perform the mitotic functions associated fine-tuning mechanism designed to prevent indiscrimi-
with Clb2p. It was not determined whether the ability to nate protein phosphorylation by untargeted (free) CDKs.
prevent rereplication is a special property of Clb2p or
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first, by lower amounts of CDK activity, and M phase
second, by higher amounts. Since the essential feature
of this model is that the amount of CDK activity deter-
mines which cell cycle event occurs, one might suppose
that the ancient function of the cyclin was to quantita-
tively control CDK activity. The multiple, qualitatively
unique cyclins seen in modern organisms would be a
fine-tuning mechanism, and not a fundamental attribute
of the cell division process.
As an alternative, F. Cross has suggested that it may
be useful to focus on the origin of cyclins as substrate-
targeting subunits rather than as quantitative effectors
of CDK activity. Perhaps ancient eukaryotes expressed
proline-directed cyclin-independent enzymes that were
the common progenitors of both cell cycle kinases
(CDKs) and signal transduction kinases (MAPKs). These
enzymes may have combined the functions of both path-
ways by responding to extracellular signals, like food,
to simultaneously initiate cell growth and chromosome
duplication. Cyclins may have first been used to facili-
tate substrate targeting by the ancestral ªCDKs,º func-
tionally separating them from the signal transduction
enzymes and ultimately from each other. The more famil-
iar role of cyclins in modulating CDK activity might have
